跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,797 条关于
“Meibomian Gland Dysfunction”
全部
9,797
临床试验
7,963
药物
42
机构
28
资讯
1,764
9个月前
Azura Ophthalmics Receives Positive FDA Feedback for First-in-Class Dry Eye Treatment Targeting Meibomian Gland Dysfunction
去年
Grandpharma's GPN01768 Receives Macao Approval for Demodex Blepharitis Treatment
去年
Novoxel and GPOphtho Partner to Expand Access to FDA-Cleared Tixel Device for Dry Eye Treatment Across US
去年
Perfluorohexyloctane Shows Promise for Dry Eye Disease in Pooled Phase 3 Analysis
9个月前
Cloudbreak Therapeutics Advances CBT-004 to Phase 3 Trials Following Successful FDA Meeting for Vascularized Pinguecula Treatment
7天前
Dupilumab-Linked Ocular Surface Disease Affects Nearly One-Third of Atopic Dermatitis Patients but Rarely Forces Discontinuation
去年
Perfluorohexyloctane Shows Unprecedented Rapid Relief for Dry Eye Disease in Phase 4 Study
去年
Dry Eye Disease Affects 16.4 Million Americans as New Targeted Therapies Enter Development Pipeline
去年
TearCare System Demonstrates Cost Savings and Superior Outcomes Compared to Cyclosporine in Dry Eye Treatment
去年
Lumenis Dynamic Muscle Stimulation Technology Shows Promise for Treating Dry Eye Disease Through Lower Lid Laxity Correction
第 1 页，共 177 页
上一页
下一页
